Source: Health Products Regulatory Authority (ZA) Revision Year: 2024 Publisher: Umsebe Healthcare, 506 Sunclare Building, 21 Dreyer Street, Claremont, Cape Town, 7708, South Africa Name of Manufacturer: Sintetica SA
Cholstyq.
| Pharmaceutical Form |
|---|
|
Solution for injection. Clear, colourless solution, practically free of visible particles. |
Each 1 ml of solution for injection contains 0,5 mg of glycopyrronium bromide and 2,5 mg neostigmine metilsulfate.
Excipient with known effect: Each 1 ml of the solution for injection contains 3 mg (0,13 mmol) sodium.
For a full list of excipients, see section 6.1.
| Active Ingredient |
|---|
|
Glycopyrronium is an inhaled long-acting muscarinic receptor antagonist (anticholinergic) for once-daily maintenance bronchodilator treatment of COPD. Glycopyrronium works by blocking the bronchoconstrictor action of acetylcholine on airway smooth muscle cells, thereby dilating the airways. |
|
Neostigmine inhibits cholinesterase activity and prolongs and intensifies the muscarinic and nicotinic effects of acetylcholine. The anticholinesterase actions of neostigmine are reversible. It is used mainly for its action on skeletal muscle and less frequently to increase the activity of smooth muscle. |
| List of Excipients |
|---|
|
Citric acid |
Cholstyq is presented in 2 ml (filled to 1 ml) Type I clear colourless glass ampoules. Ampoules are packed into outer cardboard cartons in pack sizes of 10.
Umsebe Healthcare, 506 Sunclare Building, 21 Dreyer Street, Claremont, Cape Town, 7708, South Africa
Name of Manufacturer: Sintetica SA
56/5.11/0094
24 May 2022
| Drug | Countries | |
|---|---|---|
| CHOLSTYQ | South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.